Purpose
Identification
Method(s)
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Suggested CPT Code(s)
80324
80359
New York State Approval Status

Approved

Turnaround Time

4 days

Test Includes
1 Amphetamine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/g 5 Stimulant, Anorexogenic
2 Methamphetamine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/g 5 Stimulant
3 MDA 3,4-Methylenedioxyamphetamine; Adam; MDMA Metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/g 5 Stimulant
4 MDMA 3,4-Methylenedioxymethamphetamine; Ecstasy High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/g 5 Stimulant
5 MDEA 3,4-methylenedioxyethylamphetamine; Eve High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/g 5 Stimulant

Specimen Type
Meconium
Requested Volume
5 g
Minimum Volume
5 g
Special Handling
None
Specimen Container
Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
None

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: 16 day(s)
Refrigerated: 16 day(s)
Frozen (-20 °C): 16 day(s)
1 Amphetamine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/g 5 Stimulant, Anorexogenic
2 Methamphetamine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/g 5 Stimulant
3 MDA 3,4-Methylenedioxyamphetamine; Adam; MDMA Metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/g 5 Stimulant
4 MDMA 3,4-Methylenedioxymethamphetamine; Ecstasy High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/g 5 Stimulant
5 MDEA 3,4-methylenedioxyethylamphetamine; Eve High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/g 5 Stimulant

Interface Map

LOINC® Information